565 research outputs found
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury
Chronic liver disease features constant parenchymal injury and repair together with an increasing hepatic impairment, finally leading to fibrosis and cirrhosis and a heightened risk of hepatocellular carcinoma. Closely related to the rise in obesity, the worldwide prevalence of nonalcoholic fatty liver disease, the most common form of chronic liver disease, has reached an epidemic dimension and is estimated to afflict up to 46 percent of the general population, including more than one out of three U.S. citizens. Up to now there is no effective drug treatment available, which is why recommendations encompass both exercise programs and changes in dietary habits. Exercise is well-known for unleashing potent anti-inflammatory effects, which can principally counteract liver inflammation and chronic low-grade inflammation. This review article summarizes the underlying mechanisms responsible for the exercise-mediated anti-inflammatory effects, illustrates the application in animal models as well as in humans, and highlights the therapeutic value when possible. Based on the available results there is no doubt that exercise can even be beneficial in an advanced stage of liver disease and it is the goal of this review article to provide evidence for the therapeutic impact on fibrosis, cirrhosis, and hepatocellular carcinoma and to assess whether exercise might be of value as adjuvant therapy in the treatment of chronic liver disease. In principle, all exercise programs carried out in these high-risk patients should be guided and observed by qualified healthcare professionals to guarantee the patients' safety. Nevertheless, it is also necessary to additionally determine the optimal amount and intensity of exercise to maximize its value, which is why further studies are essential
Cysteine-rich protein family of highly related LIM domain proteins
Journal ArticleHere we describe a family of closely related LIM domain proteins in avian cells. The LIM motif defines a zinc-binding domain that is found in a variety of transcriptional regulators, proto-oncogene products, and proteins associated with sites of cell-substratum contact. One type of LIM-domain protein
Standardization and Normalization of Data from Laser Ablation Inductively Coupled Plasma Mass Spectrometry
Laser ablation inductively coupled plasma mass spectrometry is a useful technique for the precise determination of major, minor and trace element distributions or isotope ratios in solid samples and biological tissue sections. However, measured ion intensities of selected mass-to-charge ratios, may vary considerably from run to run and might also underlie non-linear drift within a run. Therefore, beside the calibration of the measurement, normalization of ion intensities to a reference such as an internal standard is necessary. Other strategies use an endogenous reference element of which a homogenous distribution in the sample is assumed, or derive a more complex reference parameter from a given dataset. Generally, normalization methods depend on the experimental setup and sample material and are usually based on one or few isotopes or the total ion current. This chapter reports different normalization methods that either used a separate reference value for each data point β constituting a pixel in the isotope image β or used a constant normalization factor per measurement run. In conclusion, normalization is essential to minimize deviations of element concentrations due to measurement-related fluctuations. Normalization and definition of an area of interest are powerful tools to obtain high-contrast isotope images with absolute element concentrations
Vitamin A: too good to be bad?
Vitamin A is a micronutrient important for vision, cell growth, reproduction and immunity. Both deficiency and excess consuming of vitamin A cause severe health consequences. Although discovered as the first lipophilic vitamin already more than a century ago and the definition of precise biological roles of vitamin A in the setting of health and disease, there are still many unresolved issues related to that vitamin. Prototypically, the liver that plays a key role in the storage, metabolism and homeostasis of vitamin A critically responds to the vitamin A status. Acute and chronic excess vitamin A is associated with liver damage and fibrosis, while also hypovitaminosis A is associated with alterations in liver morphology and function. Hepatic stellate cells are the main storage site of vitamin A. These cells have multiple physiological roles from balancing retinol content of the body to mediating inflammatory responses in the liver. Strikingly, different animal disease models also respond to vitamin A statuses differently or even opposing. In this review, we discuss some of these controversial issues in understanding vitamin A biology. More studies of the interactions of vitamin A with animal genomes and epigenetic settings are anticipated in the future
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts [version 1; referees: 2 approved]
Hepatic fibrosis is characterized by the formation and deposition of excess fibrous connective tissue, leading to progressive architectural tissue remodeling. Irrespective of the underlying noxious trigger, tissue damage induces an inflammatory response involving the local vascular system and the immune system and a systemic mobilization of endocrine and neurological mediators, ultimately leading to the activation of matrix-producing cell populations. Genetic disorders, chronic viral infection, alcohol abuse, autoimmune attacks, metabolic disorders, cholestasis, alterations in bile acid composition or concentration, venous obstruction, and parasite infections are well-established factors that predispose one to hepatic fibrosis. In addition, excess fat and other lipotoxic mediators provoking endoplasmic reticulum stress, alteration of mitochondrial function, oxidative stress, and modifications in the microbiota are associated with non-alcoholic fatty liver disease and, subsequently, the initiation and progression of hepatic fibrosis. Multidisciplinary panels of experts have developed practice guidelines, including recommendations of preferred therapeutic approaches to a specific cause of hepatic disease, stage of fibrosis, or occurring co-morbidities associated with ongoing loss of hepatic function. Here, we summarize the factors leading to liver fibrosis and the current concepts in anti-fibrotic therapies
ΠΠ°Π»ΠΎΠ³ΠΎΠ²ΠΎΠ΅ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΎΡΡΡΠΎΡΠ½ΠΎΠ³ΠΎ Π±ΠΈΠ·Π½Π΅ΡΠ°
ΠΠ°Π»ΠΎΠ³ΠΎΠ²ΠΎΠ΅ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ°ΡΡΡΡ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠ΅ΠΉ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Π΅ΡΠ»ΠΈ ΡΡΠ° ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΡ ΠΊΡΡΠΏΠ½Π°Ρ. ΠΡΠΎΠ±ΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠ½ΠΎΡΡΡΡ ΠΏΠΎΠ»ΡΠ·ΡΠ΅ΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΠΎΡΡΡΠΎΡΠ½ΡΡ
ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ. Π‘ΡΡΡ ΡΠ°ΠΊΠΈΡ
ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ Π² ΠΏΠΎΠ»Π½ΠΎΠΌ ΠΈΠ»ΠΈ ΡΠ°ΡΡΠΈΡΠ½ΠΎΠΌ ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠΈ Π½Π°Π»ΠΎΠ³ΠΎΠ². Π Π΅Π³ΠΈΡΡΡΠ°ΡΠΈΡ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ Π½Π° ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠΈ Π΄ΡΡΠ³ΠΎΠΉ ΡΡΡΠ°Π½Ρ Π½Π°Π½ΠΎΡΠΈΡ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ ΡΡΠΎΠ½ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΠΊΠΈ Π ΠΎΡΡΠΈΠΈ. Π‘ ΡΠ΅Π»ΡΡ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ ΠΎΡΡΡΠΎΡΠ½ΡΡ
ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ, Π² Π ΠΎΡΡΠΈΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΏΠΎΠ»ΠΈΡΠΈΠΊΠ° Π΄Π΅ΠΎΡΡΠΎΡΠΈΠ·Π°ΡΠΈΠΈ
ΠΠ½Π°Π»ΠΈΠ· ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎΠΌ Π½Π° ΡΠ΅Π³ΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΌ ΡΡΠΎΠ²Π½Π΅
ΠΠΎΡΡΠΎΡΠ½Π½ΠΎΠ΅ ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎΠΌ ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²Π°ΠΆΠ½ΡΠΌ ΡΡΠ»ΠΎΠ²ΠΈΠ΅ΠΌ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π²ΡΡΠΎΠΊΠΎΠΉ ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠΎΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ ΠΏΡΠ΅Π΄ΠΏΡΠΈΡΡΠΈΡ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ Π²ΡΡΡΡΠΏΠ°Π΅Ρ Π³Π»Π°Π²Π½ΡΠΌ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ ΠΊΠΎΠ½ΠΊΡΡΠ΅Π½ΡΠΎΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ, ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ ΠΏΡΡΠΌΡΡ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎΠΌ ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΡΡΠ²Π°.Continuous improvement of the quality management system and product quality improvement is an important condition for maintaining high competitiveness of the enterprise. Thus, quality is the main factor of competitiveness and determines the direct relationship between quality and production efficiency
Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts
BACKGROUND: The hepatic stellate cell is the primary cell type responsible for the excessive formation and deposition of connective tissue elements during the development of hepatic fibrosis in chronically injured liver. Culturing quiescent hepatic stellate cells on plastic causes spontaneous activation leading to a myofibroblastic phenotype similar to that seen in vivo. This provides a simple model system for studying activation and transdifferentiation of these cells. The introduction of exogenous DNA into these cells is discussed controversially mainly due to the lack of systematic analysis. Therefore, we examined comparatively five nonviral, lipid-mediated gene transfer methods and adenoviral based infection, as potential tools for efficient delivery of DNA to rat hepatic stellate cells and their transdifferentiated counterpart, i.e. myofibroblasts. Transfection conditions were determined using enhanced green fluorescent protein as a reporter expressed under the transcriptional control of the human cytomegalovirus immediate early gene 1 promoter/enhancer. RESULTS: With the use of chemically enhanced transfection methods, the highest relative efficiency was obtained with FuGENEβ’6 gene mediated DNA transfer. Quantitative evaluation of representative transfection experiments by flow cytometry revealed that approximately 6% of the rat hepatic stellate cells were transfected. None of the transfection methods tested was able to mediate gene delivery to rat myofibroblasts. To analyze if rat hepatic stellate cells and myofibroblasts are susceptible to adenoviral infection, we have inserted the transgenic expression cassette into a recombinant adenoviral type 5 genome as replacement for the E1 region. Viral particles of this replication-deficient Ad5-based reporter are able to infect 100% of rat hepatic stellate cells and myofibroblasts, respectively. CONCLUSIONS: Our results indicate that FuGENEβ’6-based methods may be optimized sufficiently to offer a feasible approach for gene transfer into rat hepatic stellate cells. The data further demonstrate that adenoviral mediated transfer is a promising approach for gene delivery to these hepatic cells
Editorial: Macrophages in Liver Disease
Macrophages constitute a key component of our immune system and play an important role in immune surveillance. Hepatic macrophages are a heterogeneous population of immune cells that mainly comprises of embryonically-derived resident Kupffer cells (KCs), and circulating monocyte-derived macrophages (MoMFs). They play a critical role in disease initiation and progression as well as contribute to disease resolution. Traditionally, macrophages were defined by two broad subsets: classically-activated pro-inflammatory M1 or alternatively-activated anti-inflammatory M2 macrophages. However, it has been recognized that macrophages can differentiate into multiple phenotypes with distinct functions based on the tissue microenvironment
- β¦